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Background/aim: Healthy wound healing is very important for patient comfort. Diabetes is one of the factors that negatively affect
wound healing. Ankaferd Blood Stopper (ABS) and caffeic acid phenethyl ester (CAPE) are antiinflammatory and antimicrobial agents
and may have positive effects on wound healing.
Materials and methods: In this study, 72 male Wistar albino rats were used. Rats; control, CAPE, ABS, diabetes + control, diabetes +
ABS and diabetes + CAPE groups were divided into 6 groups. A healthy 36 rats created diabetes using streptozotocin (STZ). A gingival
wound was created using a 4-mm punch biopsy in the gingival tissue under the lower anterior incisors of the rats.
Results: The comparison between the nondiabetic groups had a statistically significant positive effect compared to the control group
of CAPE and ABS (P ˂ 0.05). In the comparison between ABS and diabetes + ABS groups and in the comparison between CAPE and
diabetes + CAPE groups, a decrease in vascularization in diabetes + CAPE groups was observed and it was statistically significant (P ˂
0.005).
Conclusion: ABS and CAPE have been found to have positive effects on gingival wound healing in the nondiabetic group. We think that
this situation is caused by its antiinflammatory and antimicrobial properties.
Key words: Ankaferd Blood Stopper, caffeic acid phenethyl ester, diabetes, gingival wound healing

1. Introduction
Wound healing in the gums includes the answers that took
place in order to close the defects in the oral mucosa. Responses in tissues are important to prevent the spread of
pathogens into the tissue and to prevent chronic infection.
Inflammatory responses play an important role after injuries, as they occur during wound healing. The wound
healing process is seriously affected by aging. After tissue
damage, a large number of biological pathways begin to
work to prevent infection and restore tissues. Cells that
increase in the wound healing process are usually neutrophils, monocytes, lymphocytes, dendritic cells, endothelial
cells, keratinocytes and fibroblasts [1].
Diabetes mellitus (DM) is a metabolic disorder characterized by chronic hyperglycemia. It is one of the most
important causes of micro and macro complications in pa-

tients [2]. Patients with diabetes are more likely to have
infections, so periodontal disease is also more likely [3].
Periodontal diseases are gingivitis due to bacterial infection. If this situation progresses, it may cause loss of the
alveolar bone, which is one of the tissues surrounding the
tooth. In recent years, it has been suggested that there is
a direct relationship between diabetes and periodontal
disease [4–6]. There is an impairment in the healing process in diabetic patients. Neutrophil responses, fibroblast
movements, and angiogenesis are defective. In this case, it
affects the wound healing process negatively [7,8].
Caffeic acid phenethyl esters (CAPE) are bioactive materials derived from the honeybee propolis extracts having antioxidant, antiinflammatory and antineoplastic. It
is stated that CAPE is also beneficial for wound healing.
CAPE has a positive impact on reducing reactive oxygen
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species (ROS) formed with plasma, lung and kidney lipid
peroxidases. It also accelerates the formation of neo-epidermis in incisional lesions. CAPE induces faster wound
contraction and new epithelial formation by reducing oxidative damage [9].
Ankaferd Blood Stopper (ABS), widely used as a hemostatic agent in Turkey. The ABS contains Glycyrrhiza
glabra, Vitis vinifera, Alpinia officinarum, Urtica dioica,
Thymus vulgaris [10]. Studies have reported that ABS has
strong antimicrobial properties along with its effectiveness
in bleeding control [11]. In the studies it was suggested
that ABS can be used in dental treatments because of its
hemostatic activity and strong antimicrobial properties
[12,13].
The aim of this study is to investigate the effects of topical ABS and CAPE on secondary healing of experimental
excisional wound areas formed in the gingival mucosa of
diabetic and nondiabetic rats.
2. Materials and methods
In this study, 72 male Wistar albino rats (mean age: 7
weeks; weight: 250–300 g) were used. To ensure the protection of experimental animals, the recommendations in
the Helsinki Declaration were fully followed. Rats were
kept at 55% humidity, room temperature 22 ± 2 °C and
12 h light/dark cycle. Rats were kept separately in a controlled room (21 °C and 12 h light/12 h dark cycle) and in
cages where they could freely access water and food. Rats
were divided into 6 groups; control, CAPE, ABS, diabetes
+ control, diabetes + ABS and diabetes + CAPE groups.
In these six groups, 4-mm mucosal defects were created
in gingiva. The rats in the ABS and diabetes + ABS groups

were applied topically with 0.2 mL of ABS solution. Rats
in the CAPE and diabetes + CAPE groups were applied 50
mmol/kg of CAPE topically. Pressure was applied with a
sterile pad until bleeding control was achieved. All treatments were applied for 14 and 21 days (n = 6).
2.1. Diabetes process in rats
Streptozotocin is a narrow-spectrum antibiotic with diabetogenic properties and has toxic effects on beta cells of
Langerhans islets in the pancreas. It also has a genotoxic
effect. Usually, a single dose of streptozotocin (40–65 mg/
kg, intraperitoneal) is used to develop diabetes [14]. Streptozotocin (STZ) (Sigma Chemical Co., St. Louis, MO,
USA) intraperitoneal injection was performed with 50
mg/kg of 0.2 mL 10 mM citrate solution to 36 healthy rats.
One week later, blood glucose levels were measured in rats
(Optima blood glucose meter, Hausverwaltung Optima
GmbH, Hannover, Germany). If the blood glucose value
was 350 mg/dL, the rats were accepted as diabetic [15].
2.2. Surgical procedure
The animals were fasted for 8 h before performing surgical procedures and general anesthesia. Surgical procedures
were performed under sterile conditions and under general anesthesia. Xylazine hydrochloride (Rompun, Bayer,
Leverkusen, Germany, 10 mg/kg) and ketamine hydrochloride (Ketasol, Richter Pharma, Wels, Austria, 40 mg/
kg) were used as general anesthetics. General anesthetics
were administered intramuscularly with the help of an insulin injector. A full-thickness gingival wound was created
using a 4-mm punch biopsy in the gingival tissue under
the lower anterior incisors of the rats (Figure 1). Rats are
monitored daily for signs of pain, infection, limited move-

Figure 1. 4-mm defect created on gingival mucosa.
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ment, anorexia, and weight loss after surgery. Antibiotic
(50 mg/kg penicillin) and analgesic (0.1 mg/kg tramadol
hydrochloride) were applied i.m. to prevent infection and
pain after surgery. They were applied once in every 24 h for
3 days. Subjects were sacrificed on the 14th and 21st days.
After the surgical procedures, the wound area was left to
heal. Sacrification was done using sodium thiopentone
(lethal dose: 60 mg/kg). The tissue in the wound area was
excised together with healthy tissues. Tissues taken were
kept in 10% formaldehyde for histological evaluation,
while tissues to be analyzed with real-time PCR were kept
at –80 °C until analysis time.
2.3. Histopathological method
Gingival tissue was directly put in neutral buffered formalin fixative. After complete fixation of the removed tissues,
it was kept under running water for 12 h. Then, for the de-

hydration process, tissues were kept in gradually increasing alcohol series (30%, 50%, 70%, 80%, 90%, 96% and
100%) for 12 h. After the xylol transparency, the tissues
were infiltrated and embedded in paraffin blocks. Six-µm
sections were obtained from paraffin blocks and stained
with hematoxylin-eosin dye for routine dyeing.
Light microscopic evaluation was performed in sections of 6-µm thickness of gingival wound area. Gingival
wound healing were evaluated using an image analysis
program for inflammation (grading 0–4), epithelialization
and vascularization. All images of histological samples
were obtained from a digital camera connected to a light
microscope. The images were transferred to the computer
in original magnification. Histological analysis was performed with the help of Olympus DP71 (Tokyo, Japan)
software imaging system (Figures 2a–2l).

Figure 2. Hematoxylin-eosin staining bar 200 µm: a)14th day ABS group, b)14th day CAPE group, c) 14th day control group, d)21st day
ABS group, e)21st day CAPE group, f) 21st day control group, g)14th day diabetes + ABS group, h)14th day diabetes + CAPE group, ı)
14th day diabetes + control group, j) 21st day diabetes + ABS group, k) 21st diabetes + CAPE group, l) 21st diabetes + control group.
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2.4. RNA isolation, cDNA synthesis and qRT-PCR analysis
Tissue samples were taken into mRNA storage solution
and stored at –80 °C. High Pure RNA Tissue Kit Tisssue
(Roche 12 033 674 001, Roche Diagnostics, Risch-Rotkreuz, Switzerland) protocol was followed and samples
were homogenized and RNA isolation was performed.
RNA purity and integrity were checked with a nanodrop
device. With the Transcriptor First Standard cDNA Synthesis Kit (Roche 04896866001), cDNA was made according to the procedure [16,17].
In the real-time PCR study, the following primer sequences were used for TNF-α, IL-6, e-Nos, and target
genes with ACTB (beta actin) reference gene (Table 1). LC
DNA Master SYBR Green I kit (Roche 04707516001) was
used [17]. PCR mixing protocol real-time PCR (mastermix), 3 µLddH2O, 10 µL LightCycler 480 DNA Master
SYBR Green I2x conc, Primer. Forward (Target or ACTB)
1.0 µL, Primary Reverse (Target or ACTB) 1.0 µL, total
mix volume 15, µL and 3.0 µL of each Target cDNA on
top of this mixture, with a final concentration volume of
18 µL was studied. Real-time PCR protocol, on the other
hand, was performed with 30 s cooling at 1 cycle 95 °C, 30
s at 95 °C for 45 cycles, 30 s at 60 °C, 20 s at 72 °C, and 30
s at 1 cycle 40 °C. Working with Lightcycler real-time PCR
device. Then, the concentration values determined according to the crossing point (Cp) results of the samples were
obtained with the 2-∆∆CT method (Figures 3a–3c).
2.5. Statistical analysis
Statistical analysis of the data in our study was done using SPSS 20.0 for Windows (IBM Corp., Armonk, NY,
USA) statistical program. Histological and PCR data
with descriptive statistics; numerical values are shown as
mean arithmetic values (M) and standard deviation (SD)
values. Wilcoxon test was used for nonparametric data.
The normal distribution of the data was evaluated with
the Shapiro–Wilk test. Mann–Whitney U test was used
to compare the nonnormally distributed data between the

two groups and the Kruskal–Wallis test was used for more
than two groups. In comparing more than two groups, the
Mann–Whitney U test with Bonferroni correction was
performed. In all statistical tests, P < 0.05 value was considered significant.
3. Results
As a result of histological analysis performed on the 14th
day: In the CAPE group, a decrease in inflammation was
detected compared to the control group and it was found
statistically significant (P = 0.045). In addition, a decrease
in inflammation was detected in the ABS group compared
to the control group, which was found statistically significant. Also, an increase in inflammation was observed in
the diabetes + ABS group compared to the ABS group,
which was found statistically significant (P = 0.007). On
the 14th day, an increase in epithelialization was observed
in the CAPE and ABS group compared to the control
group and was found statistically significant (P = 0.014, P
= 0.07). No significant difference was observed in epithelialization in the diabetic group compared to the control
group. However, in comparison between diabetes + ABS
and ABS group and between diabetes + CAPE group and
CAPE group, a decrease in epithelialization was found in
diabetic groups and it was found statistically significant (P
= 0.007, P = 0.006). On the 14th day, vascularization increased in the CAPE group compared to the control group
and was found statistically significant (P = 0.041). In addition, in the comparison between ABS and diabetes + ABS
groups and in the comparison between CAPE and diabetes
+ CAPE groups, a decrease in vascularization in diabetes +
CAPE groups was observed and it was statistically significant (P = 0.006, P = 0.041, Table 2).
As a result of histological analysis performed on the
21st day: An increase in vascularization was detected in
the CAPE group compared to the control group, and it was
found statistically significant (P = 0.041). No statistically
significant difference was found between other groups (P
˃ 0.05, Table 2).

Table 1. Primers base pairs sequence of the expression gens.
Oligonucleotide ID
TNF-α
e-NOS

Nucleotide sequence
5’- GCAGGTCTACTTTGGAGTCATT -3’
5’- GGCTCTGAGGAGTAGACGATAA -3’
5’- CCGGCGCTACGAAGAATG-3’
5’- CAGTGCCACGGATGGAAATT-3’

IL-6

5’- CCACCAGGAACGAAAGTCAA -3’
5’- TCAACAACATCAGTCCCAAGAA -3’

ACTB

5‘-AGATGACCCAGATCATGTTTGAGA-3’
5’-ACCAGAGGCATACAGGGACAA- 3’

Accession
Roy et al., 2018
Hermawatı et al., 2018
Our design
Yono et al., 2009
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Figure 3. Target genes amplification curves real-time PCR data a) TNF-α, b) IL-6, c)
e-NOS.

As a result of the PCR analysis: IL-6 levels were evaluated and no significant difference was found on the 14th
day. On the 21st day, a statistically significant difference was found between control and ABS groups, control + diabetes and ABS + diabetes groups and between
ABS and ABS + diabetes groups (P ˂ 0.05). TNF-α levels
were evaluated and there was no statistically significant
difference between the groups on the 14th day (P ˃ 0.05).
On the 21st day; a statistically significant difference was
found between control and CAPE groups and between
ABS and CAPE groups (P ˂ 0.05) (Table 3). e-NOS
levels were evaluated and an increase was observed in
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the groups with ABS and CAPE on the 14th day and was
found statistically significant (P ˂ 0.05). In addition, in
the analysis performed on the 21st day, an increase was
detected in the ABS group compared to the control group
and it was found statistically significant (P = 0.016, Table
3).
4. Discussion
Many factors have negative effects on wound healing at
various stages of the wound healing process. These factors
disrupt tissue production and delay wound healing [18].
Kido et al., created diabetes by applying Streptozotocin to

GÜL et al. / Turk J Med Sci
Table 2. Histopathological comparison between groups on 14 and 21 days.
Control+ ABS +
Days Control
ABS
CAPE
diabetes
diabetes
14

1.67 ± 0.82 0.83±
0.41

21

2.50 ± 0.55 2.17 ± 0.75

CAPE + diabetes P* value Intergroup P value
2.33 ± 0.82

0.001

1.00 ± 0.63

0.67 ±
0.67 ± 0.52 2.00 ± 0.80 2.00 ± 0.89 2.00 ± 0.89
0.82

0.010

0.150

0.523

1.67 ± 0.52

2.67 ±
1.33 ± 0.52
3.00 ± 0.63
1.50 ± 0.55
0.52
1.33 ± 0.52

0.001

2.67 ± 0.82

3.33 ±
3.33 ± 0.82 2.17 ± 0.41 2.17 ± 1.17 1.83 ± 0.41
0.52

0.007

0.031

0.056

14

2.67 ± 0.82

3.50 ±
3.67 ± 0.52 2.17 ± 0.75 2.00 ± 0.63 2.67 ± 0.82
0.55

0.004

21

2.17 ± 0.75

2.83 ±
3.33 ± 0.52 2.33 ± 0.82 1.83 ± 0.41 2.50 ± 0.55
0.75

0.014

0.337

0.116

Inflammation

Intergroup P value
14
Epithelisation
21
Intergroup P value

Vascularization

Intergroup P value

0.83 ± 0.41

0.523

0.382

0.269

0.299

0.018

0.665

0.733

0.163

0.598

0.045a, 0.045b,
0.995c, 0.423d, 0.789e,
0.665f, 0.007g, 0.007h
0.382a, 0.336b, 0.859c,
0.981d, 0.906e ,
0.935f, 0.031g, 0.016h

0.495
0.014a, 0.007b,
0.336c, 0.986d, 0.575e,
0.575f, 0.007g, 0.006h
0.118a, 0.176b, 0.860c,
0.788d, 0.176e, 0.719f,
0.65g,
0.007h

0.241
0.073a, 0.041b,
0.576c, 0.652d, 0.337e,
0.150f, 0.006g, 0.041h
0.167a, 0.016b,
0.206c, 0.176d,
0.789e, 0.043f,
0.019g, 0.030h

0.789

a: Comparison between control and ABS groups, b: Comparison between control and CAPE, c: Comparison between ABS and CAPE
groups, d: Comparison between control + diabetes and ABS + diabetes groups, e: Comparison between control + diabetes and CAPE +
diabetes groups, f: Comparison between ABS + diabetes and CAPE + diabetes groups, g: Comparison between ABS and ABS + diabetes
groups, h: Comparison between CAPE and CAPE + diabetes groups, P < 0.05, significance, P *, Kruskal–Wallis test, P, Wilcoxon test.

the rats and formed wounds in the palatal region. They
evaluated wound healing that occurred in the wound area.
They reported a delay in wound healing on days 7, 14, and
21. They determined the number of subjects used in each
group to be 6 [19]. The contraction of the wound begins
after the injury and peaks on the 14th day. The degree of
contraction of the wound varies depending on the depth of
the wound. Up to 40% reduction in the size of the wound
occurs in full-thickness wounds. The total amount of collagen increases in the early period of the repair. It reaches
its maximum after 14 and 21 days of injury [20].
In our study, rats were made diabetic using streptozotocin. Then a secondary wound was created in 4-mm
full-thickness gingiva. The number of subjects was determined as 6 for each group. Vascularization, epithelialization and inflammation were evaluated histologically on
the 14th and 21st days. TNF-α, e-NOS and IL-6 was evaluated by PCR analysis method on the 14th and 21st days.
Salles et al. created an 8-mm wound in mice and diabetic mice with streptozotocin. Then, they applied CAPE
to the wound area to evaluate the antioxidant and antiinflammatory properties of CAPE in diabetic mice. The

diabetes + CAPE group suggested that there was a strong
tendency towards more contraction and reepithelialization compared to the diabetes group, and treatment of
diabetic lesions with CAPE is a good option for a therapeutic treatment with the benefit of being a natural source
product that can reduce the wound healing complications
of diabetes [21]. Magro-Filho and de Carvalho reported
that CAPE’s topical application of wound surfaces reduces
inflammation in oral cavity surgery [22]. Armutcu et al.
have reported that CAPE exhibits strong antioxidant, antiinflammatory and wound healing properties due to nuclear factor-κB inhibition [23].
Similarly, in our study, a decrease in inflammation, an
increase in epithelialization and vascularization was observed on day 14 between the CAPE-treated nondiabetic
group and the nondiabetic control group, and it was found
statistically significant. Among the comparison between
diabetes-treated groups, there was a statistically significant
difference in the CAPE-treated groups on the 14th day,
although inflammation decreased, epithelialization and
vascularization increased. On the 21st day, there was no
significant difference in inflammation and epithelializa-
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Table 3. Comparison of Tnf- α, IL- 6 and e-NOS with real-time PCR analysis between groups on 14 and 21 days.
Days Control
14
PCR
IL-6

21

P value
between
groups
PCR
TNF-α

14
21

P value
between
groups

PCR
e-NOS

14

21
P value
between
groups

ABS

CAPE

Control+
diabetes
14.85 ± 1.22

ABS +
diabetes
17.02 ± 4.79

CAPE +
diabetes
18.47 ± 5.22

19.69 ±
13.04

16.90 ± 40.93 ±
10.48
8.24

8.31±4.10

18.80 ± 16.64 ±
9.02
6.68

40.41± 10.14

5.94± 2.54

23.91± 9.41

NS

NS

NS

NS

NS

NS

1.74 ± 0.41

1.06 ±
0.21

3.74 ±
1.97

1.77 ± 0.02

3.42 ± 1.45

6.25 ± 2.88

1.08 ± 0.42

1.33 ±
0.95

2.62 ±
0.84

12.30 ± 5.93

1.15 ± 0.53

5.33 ± 2.61

0.337

0.522

0.748

0.078

0.200

0.749

P* value
0.869
0.011

0.312
0.006

1.10 ± 0.67

5.33 ±
2.39

8.02 ±
4.84

4.23 ± 1.39

4.96 ± 1.34

8.77 ± 1.22

0.011

2.91 ± 1.19

7.50 ±
2.51

3.88 ±
2.70

22.22 ± 10.91 2.08 ± 0.66

5.38 ± 2.08

0.031

0.020

0.262

0.078

0.337

0.037

P value between groups
NS
0.025a. 0.055b. 0.631c.
0.016d.
0.337e. 0.055f. 0.025g.
0.423h

NS
0.423a. 0.006b
0.030c. 0.078d.
0.522e. 0.055f. 0.631g.
0.630h

0.004a. 0.006b. 0.262c.
0.873d.
0.873e. 0.995f. 0.631g.
0.632h
0.016a. 0.263b. 0.078c.
0.200d.
0.873e. 0.200f. 0.006g.
0.522h

0.936

a: Comparison between control and ABS groups, b: Comparison between control and CAPE, c: Comparison between ABS and CAPE
groups, d: Control + diabetes versus ABS + diabetes groups, e: Control + diabetes and CAPE + diabetes groups comparison, f: Comparison
between ABS + diabetes and CAPE + diabetes groups, g: Comparison between ABS and ABS + diabetes groups, h: Comparison between
CAPE and CAPE + diabetes groups, P < 0.05, significance, NS: Not significant, P *, Kruskal–Wallis test, P, Wilcoxon test.

tion, however, a statistically significant increase in vascularization was observed in the CAPE group compared to
the control group.
Topal et al. evaluated effects of ABS and silver sulphadiazine (SSD) cream on burn wounds on days 0, 7, 14, 21,
28. All rats in the ABS and SSD groups were completely
covered by granulation tissue and epithelized, however,
the wounds in the control group were not epithelialized
completely. On the 7th day, mean wound areas that did not
heal and mean wound contraction rates did not show a significant difference between the groups. They reported that
the mean percentage of wound contraction in the ABS and
SSD groups was significantly higher at 14, 21 and 28 days
than in the control group. They reported that, wound healing is characterized by a decrease in neutrophil count and
an increase in vascular count, and that ABS, as well as SSD,
can be successfully used in burn wound healing [24]. In a
study by Akalin et al., they created a full-thickness wound
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defect and applied ABS. They examined the contraction
percentage histopathologically and reported that the ABS
had a positive effect on wound healing [25]. Pamuk et al.
suggested that ABS induces an increase in soft tissue healing by stimulating angiogenesis and vascular endothelial
cell function in the treatment of periodontal defects using
autogenous cortical bone graft. They also reported that it
prevented gingival recession and thus increased clinical attachment gain [26]. Keceli et al. reported that the application of medical herbs positively contributed to soft tissue
healing [27].
Similarly in our study, ABS was applied on the 14th
and 21st days. On day 14, a decrease in inflammation, an
increase in epithelialization and vascularization was observed compared to the control group, and it was found
statistically significant. This situation shows us that ABS
has a positive effect on wound healing. In the comparison made between diabetes + control and diabetes + ABS

GÜL et al. / Turk J Med Sci
groups, no significant difference was found, although a
decrease in inflammation was detected. We think that the
effect of ABS in diabetic wound healing should be investigated with further studies.
Many studies have reported that various cell sources
contribute to the production of wound cytokines [28].
Previous studies examining the effect of IL-6 on the healing process have shown that IL-6 has a negative impact
on wound healing by prolonging the colon wound healing process [29]. There are studies showing that IL-6 has
a positive role in wound healing, suggesting that it speeds
up the healing process in skin wound healing [30]. It has
been suggested that TNF-α and IL-6 have negative effects
on wound healing [31]. Studies have shown that adequate
nitric oxide (NO) production is required for effective
wound healing and topical application of NO accelerates the closure of excisional wounds in diabetic rats [32].
Also, impaired angiogenesis was established in mice with
e-NOS deficiency [33]. In previous studies, it was reported
that NO plays an important role in antimicrobial mechanisms by reducing bacterial loads in wound areas. It has
also been suggested that when skin injury occurs, it forms
a structure so that the injured tissue is not invaded by microbial pathogens [34].
In our study, when the IL-6 levels were evaluated, no
significant difference was found between the groups on the
14th day. On the 21st day, a significant increase was observed in the IL-6 level in the ABS group compared to the
control group. In the comparison between diabetes and di-

abetes + ABS, the first IL-6 levels were significantly lower
in the ABS group. This shows that ABS has a positive effect
on diabetic wound healing. On day 21, an increase in inflammation was observed in the CAPE group. On the 14th
day of e-NOS, an increase was observed in both CAPE and
ABS groups and it was found statistically significant. This
shows us that both ABS and CAPE positively affect wound
healing per day.
In conclusion, in this study, the effects of ABS and
CAPE on the secondary wound healing in experimentally
created excisional wounds on the gingival mucosa of diabetic and nondiabetic Wistar albino rats were evaluated
by histological and PCR analysis methods. It is found that
ABS and CAPE were successful as local agents in the nondiabetic group. The positive effects of ABS and CAPE in
the early stage of wound healing were detected. ABS and
CAPE can be useful in wound healing in periodontal and
even oral surgery. It is necessary to shed light on the clinical effects on gingival wound healing by conducting studies on postoperative and long-term results following ABS
and CAPE administration.
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